A prospective, randomized, double-blind crossover study on the use of 5% citrate lock versus 10% citrate lock in permanent hemodialysis catheters

Blood Purification

Volumn 23, Issue 2, 2005, Pages 101-105

  Meeus, Gert ^a   Kuypers, Dirk R J ^a,b   Claes, Kathleen ^a   Evenepoel, Pieter ^a   Maes, Bart ^a   Vanrenterghem, Yves ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Dept Nephrology Ren Transplant ^*  (Belgium)

Author keywords

Anticoagulation; Citrate lock; Dialysis catheter; Trisodium citrate

Indexed keywords

CITRATE TRISODIUM; UROKINASE;

AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HEMODIALYSIS; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; VASCULAR ACCESS;

AGED; BLOOD COAGULATION; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CITRIC ACID; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EQUIPMENT FAILURE; FEMALE; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 16344394305     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083203     Document Type: Article

References (15)

1. III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: Update 2000. Am J Kidney Dis 2001;37:S137-S181.
2. Miller PE, Tolwani A, Luscy CP, et al: Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Kidney Int 1999;56:275-280.
3. Trivedi HS, Twardowski ZJ: Use of double-lumen dialysis catheters. Loading with locked heparin. ASAIO J 1997;43:900-903.
4. Hendrickx L, Kuypers D, Evenepoel P, et al: A comparative, prospective study on the use of low concentrate citrate lock versus heparin lock in permanent dialysis catheters. Int J Artif Organs 2001;24:208-211.
5. Stas KJ, Vanwalleghem J, De Moor BD, et al: Trisodium citrate 30% vs heparin 5% as catheter lock in the interdialytic period in twin- or double-lumen dialysis catheters for intermittent hemodialysis. Nephrol Dial Transplant 2001;16:1521-1522.
6. Bayes B, Bonal J, Romero R: Sodium citrate for filling hemodialysis catheters. Nephrol Dial Transplant 1999;14:2532-2533.
7. Weijmer MC, Debets-Ossenkopp YJ, Van de Vondervoort FJ, et al: Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant 2002;17:2189-2195.
8. US Food and Drug Administration: FDA Issues Warning on Tricitasol Dialysis Catheter Anticoagulant. FDA Talk Paper TOO-16, 14 April, 2000.
9. Tokars JI, Light P, Anderson J, et al: A prospective study of vascular access infections at seven outpatient hemodialysis centers. Am J Kidney Dis 2001;37:1232-1240.
10. Weijmer MC, Van den Dorpel MA, Van Geelen JA, et al: Substantial reduction of infectious complications in hemodialysis patients with trisodium citrate 30% as catheter locking solution: A prospective multicenter double-blind randomized controlled trial (abstract). J Am Soc Nephrol 2003;14:54A.
11. Weijmer MC, Van den Dorpel MA, Van Geelen JA, et al: Reduction of bleeding complications in hemodialysis patients with high concentration trisodium citrate for hemodialysis catheter locking; a prospective multicenter double-blind randomized controlled trial (abstract). J Am Soc Nephrol 2003;14:242A.
12. Polaschegg HD, Sodemann K: Risks related to catheter locking solutions containing concentrated citrate. Nephrol Dial Transplant 2003;18;2688-2690.
13. Uhl L, Maillet S, King S, et al: Unexpected citrate toxicity and severe hypocalcemia during apheresis. Transfusion 1998;37:1063-1065.
14. Betjes MGH, van Agteren M: Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 2004;19:1546-1551.
15. Dogra GK, Herson H, Hutchison B, et al: Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: A randomized controlled study. J Am Soc Nephrol 2002;13:2133-2139.